Davis George Eric — SEC Form 4 filings

SEC reporting owner CIK 1380710. 11 Form 4 filings on record with FilingPulse; latest filed 2026-09-03.

Transaction summary — filings shown

Covers all 11 filings on record, filed 2024-02-29 to 2026-09-03. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
BIOMARIN PHARMACEUTICAL INC (BMRN)EVP, Chief Legal Officer116 legs · 110,920 sh · $8,137,26224

Form 4 filings — Davis George Eric

FiledFormIssuerReported transactionsSource
2026-09-034BIOMARIN PHARMACEUTICAL INC (BMRN)Sale (S): 17,557 @ $66.28EDGAR
2026-03-194BIOMARIN PHARMACEUTICAL INC (BMRN)Tax withholding (F): 1,273 @ $56.05EDGAR
2026-03-174BIOMARIN PHARMACEUTICAL INC (BMRN)Tax withholding (F): 7,177 @ $58.51 · Grant/award (A): 14,570 @ $0 · Grant/award (A): 34,690 (derivative) @ $0EDGAR
2026-02-264BIOMARIN PHARMACEUTICAL INC (BMRN)Grant/award (A): 6,177 @ $0 · Grant/award (A): 6,675 @ $0 · Grant/award (A): 2,372 @ $0 · Sale (S): 26,061 @ $61.36EDGAR
2025-03-184BIOMARIN PHARMACEUTICAL INC (BMRN)Tax withholding (F): 16,249 @ $69.44 · Grant/award (A): 12,940 @ $0 · Grant/award (A): 30,020 (derivative) @ $0EDGAR
2025-02-274BIOMARIN PHARMACEUTICAL INC (BMRN)Grant/award (A): 11,040 @ $0 · Grant/award (A): 9,660 @ $0 · Grant/award (A): 9,367 @ $0EDGAR
2024-05-304BIOMARIN PHARMACEUTICAL INC (BMRN)Option exercise (M): 40,850 @ $63.10 · Sale (S): 38,071 @ $74.45 · Sale (S): 2,779 @ $75.29 · Option exercise (M): 40,850 (derivative) @ $0EDGAR
2024-05-064BIOMARIN PHARMACEUTICAL INC (BMRN)Grant/award (A): 301 @ $68.65 · Option exercise (M): 1,850 @ $63.10 · Sale (S): 1,850 @ $85.01 · Option exercise (M): 1,850 (derivative) @ $0EDGAR
2024-04-014BIOMARIN PHARMACEUTICAL INC (BMRN)Sale (S): 24,602 @ $88.34EDGAR
2024-03-194BIOMARIN PHARMACEUTICAL INC (BMRN)Grant/award (A): 10,260 @ $0 · Tax withholding (F): 21,699 @ $83.87 · Grant/award (A): 22,990 (derivative) @ $0EDGAR
2024-02-294BIOMARIN PHARMACEUTICAL INC (BMRN)Grant/award (A): 20,840 @ $0 · Grant/award (A): 9,063 @ $0 · Grant/award (A): 6,284 @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1380710 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →